Clinical Research in Paediatric Psychopharmacology

  • ID: 4454887
  • Book
  • 512 Pages
  • Elsevier Science and Technology
1 of 4

Clinical Research in Paediatric Psychopharmacology: An Overview of the Ethical, Scientific and Regulatory Aspects provides a practical guide and overview of the ethical, scientific and regulatory aspects of clinical research in pediatric psychopharmacology, also discussing practical points to consider when developing clinical research in this field. The book is ideal for professionals involved in clinical research in pediatric psychopharmacology, i.e., including, but not limited to pediatricians, health care professionals, researchers, investigators, pharmaceutical company personals and potentially ethics committee members.

Topics discussed include the role of patient organization and advocacy groups in research, the role of families and patients: 'should I involve my kid in a clinical research?, and historical, ethical, regulatory, clinical, scientific, intercultural and practical aspects of clinical research in child and adolescent psychopharmacology.

  • Covers both theoretical and practical aspects
  • Develops different angles from the regulatory frame, to the patient perspective
  • Proposes insights rather than tips
  • Offers future perspective for pediatric development
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
2. Historical perspective
3. Regulatory changing environment
rest of World & WHO
4. Scientific
state of the art
child and adolescent psychopharmacology at the beginning of the 21st century
5. Ethical aspects of research in paediatric psychopharmacology
including ethics committee interactions, consent and assent procedures
6. Clinical development
practical considerations
writing protocols
running clinical trials
specific paediatric formulation
proactive patient recruitment strategies. (the largest chapter)
7. Patients and family perspective
if it was my child?
8. Intercultural aspects
risks of clinical trial colonialism
global paediatric development
9. Future methodological perspectives
including simulation, modeling and extrapolation
innovation in child and adolescent psychiatry
10. Future of child and adolescent psychopharmacological research
11. Conclusion
12. References
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Auby, PhilippeDr Philippe Aubyis a Child and Adolescent Psychiatrist. He started his residency training in Psychiatry in 1986 and received his MD from the Toulouse University of Medicine, France. In 1989 and 1990, for his military service, the author worked as a psychiatrist in South East Refugee Camps in Thailand. After an initial training in adult psychiatry, he completed a board certification in child and adolescent psychiatry and a post-graduate diploma in psychology. His main research interests are in child and adolescent psychiatry, schizophrenia, bipolar disorders, PTSD, consultation/liaison psychiatry and inter-cultural psychiatry. In 1996 he joined a CRO based in Paris before moving first to Eli Lilly France then to BMS France. In 2001, he moved to BMS European Headquarter in Belgium prior working for Otsuka America Pharmaceutical, in Princeton as Executive Director-CNS Abilify in 2004. Early 2007, he moved to Lundbeck to create the International Clinical Research Department of Paediatric Neuro-Psychiatry. His current title is Senior Medical Director, Corporate ICR France & Paediatrics.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown